Welcome to LookChem.com Sign In|Join Free
  • or
(E)-N,N-dimethyl-3-(2,6,6-trimethylcyclohex-1-en-1-yl)acrylamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

52209-30-0

Post Buying Request

52209-30-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

52209-30-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 52209-30-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,2,0 and 9 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 52209-30:
(7*5)+(6*2)+(5*2)+(4*0)+(3*9)+(2*3)+(1*0)=90
90 % 10 = 0
So 52209-30-0 is a valid CAS Registry Number.

52209-30-0Downstream Products

52209-30-0Relevant academic research and scientific papers

Photocatalytic e → Z Isomerization of β-Ionyl Derivatives

Livingstone, Keith,Tenberge, Marius,Pape, Felix,Daniliuc, Constantin G.,Jamieson, Craig,Gilmour, Ryan

, p. 9677 - 9680 (2019/11/29)

An operationally simple E → Z isomerization of activated dienes, based on the β-ionyl motif intrinsic to retinal, is reported using inexpensive (-)-riboflavin (vitamin B2) under irradiation at 402 nm. Selective energy transfer from photoexcited (-)-riboflavin to the starting E-isomer enables geometrical isomerization. Since the analogous process with the Z-isomer is inefficient, microscopic reversibility is circumvented, thereby enabling a directional isomerization to generate the contra-thermodynamic product (up to 99% yield, up to 99:1 Z/E). Prudent choice of photocatalyst enables chemoselective isomerization to be achieved in both inter- and intramolecular systems. The principles established from this study, together with a molecular editing approach, have facilitated the development of a regioselective isomerization of a truncated triene based on the retinal scaffold.

OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE

-

Page/Page column 95-96, (2010/12/31)

Compounds and compositions of said compounds along with methods of use of compounds are disclosed for treating ophthalmic conditions related to mislocalization of opsin proteins, the misfolding of mutant opsin proteins and the production of toxic visual cycle products that accumulate in the eye. Compounds and compositions useful in the these methods, either alone or in combination with other therapeutic agents, are also described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 52209-30-0